Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06340958
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-03-25
Brief Title:
A Study of CLE-100 Oral Esketamine as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder
Sponsor:
Organization:
Clexio Biosciences Ltd